Insider · CIK 0001835184

D'Adamio Anthony

Reports to the SEC for 1 company · DURHAM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001835184

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-04-10	BVSBioventus Inc.M Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	+9,925 sh	—	—	157,967
2026-04-10	BVSBioventus Inc.F Tax Payment	SVP & General Counsel	FTax Payment	−4,312 sh	$9.06	−$39.1K	153,655
2026-04-10	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	−9,925 sh	—	—	9,925
2026-03-13	BVSBioventus Inc.M Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	+8,886 sh	—	—	146,955
2026-03-13	BVSBioventus Inc.F Tax Payment	SVP & General Counsel	FTax Payment	−3,861 sh	$8.62	−$33.3K	143,094
2026-03-13	BVSBioventus Inc.M Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	+8,750 sh	—	—	151,844
2026-03-13	BVSBioventus Inc.F Tax Payment	SVP & General Counsel	FTax Payment	−3,802 sh	$8.62	−$32.8K	148,042
2026-03-13	BVSBioventus Inc. · Restricted Stock UnitsA Award	SVP & General Counsel	AAward	+83K sh	—	—	83,000
2026-03-13	BVSBioventus Inc. · Stock Option (Right to Buy)A Award	SVP & General Counsel	AAward	+92K sh	—	—	92,000
2026-03-13	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	−8,886 sh	—	—	0
2026-03-13	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	−8,750 sh	—	—	26,250
2026-02-15	BVSBioventus Inc.M Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	+13K sh	—	—	144,396
2026-02-15	BVSBioventus Inc.F Tax Payment	SVP & General Counsel	FTax Payment	−6,327 sh	$8.27	−$52.3K	138,069
2026-02-15	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	−13K sh	—	—	25,960
2025-04-11	BVSBioventus Inc.S Sale	SVP & General Counsel	SSale	−2,958 sh	$7.57	−$22.4K	131,416
2025-04-10	BVSBioventus Inc.M Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	+9,925 sh	—	—	134,374
2025-04-10	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	−9,925 sh	—	—	19,850
2025-03-17	BVSBioventus Inc.S Sale	SVP & General Counsel	SSale	−2,615 sh	$9.75	−$25.5K	124,449
2025-03-14	BVSBioventus Inc.M Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	+8,886 sh	—	—	127,064
2025-03-14	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	−8,886 sh	—	—	8,886
2025-03-14	BVSBioventus Inc. · Restricted Stock UnitsA Award	SVP & General Counsel	AAward	+35K sh	—	—	35,000
2025-03-14	BVSBioventus Inc. · Stock Option (Right to Buy)A Award	SVP & General Counsel	AAward	+40K sh	—	—	40,000
2025-02-18	BVSBioventus Inc.S Sale	SVP & General Counsel	SSale	−4,380 sh	$10.19	−$44.6K	118,178
2025-02-15	BVSBioventus Inc.M Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	+13K sh	—	—	122,558
2025-02-15	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	−13K sh	—	—	38,940
2024-12-23	BVSBioventus Inc.S Sale	SVP & General Counsel	SSale	−5,848 sh	$10.53	−$61.6K	109,578
2024-12-20	BVSBioventus Inc.M Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	+19.9K sh	—	—	115,426
2024-12-20	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	−19.9K sh	—	—	0
2024-06-21	BVSBioventus Inc.S Sale	SVP & General Counsel	SSale	−5,904 sh	$5.57	−$32.9K	95,576
2024-06-20	BVSBioventus Inc.M Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	+19.9K sh	—	—	101,480
2024-06-20	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	−19.9K sh	—	—	19,850
2024-06-17	BVSBioventus Inc.S Sale	SVP & General Counsel	SSale	−11.3K sh	$5.84	−$66K	81,630
2024-06-15	BVSBioventus Inc.M Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	+34.7K sh	—	—	92,938
2024-06-15	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	−34.7K sh	—	—	0
2024-04-11	BVSBioventus Inc.S Sale	SVP & General Counsel	SSale	−3,054 sh	$4.75	−$14.5K	58,242
2024-04-10	BVSBioventus Inc.M Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	+9,925 sh	—	—	61,296
2024-04-10	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	−9,925 sh	—	—	29,775
2024-03-15	BVSBioventus Inc. · Restricted Stock UnitsA Award	SVP & General Counsel	AAward	+51.9K sh	—	—	51,920
2024-03-15	BVSBioventus Inc. · Restricted Stock UnitsA Award	SVP & General Counsel	AAward	+34.7K sh	—	—	34,696
2024-03-15	BVSBioventus Inc. · Stock Option (Right to Buy)A Award	SVP & General Counsel	AAward	+120K sh	—	—	120,000
2024-03-15	BVSBioventus Inc.S Sale	SVP & General Counsel	SSale	−3,125 sh	$5.46	−$17.1K	51,371
2024-03-14	BVSBioventus Inc.M Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	+8,886 sh	—	—	54,496
2024-03-14	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	−8,886 sh	—	—	17,772
2023-06-20	BVSBioventus Inc. · Restricted Stock UnitsA Award	SVP & General Counsel	AAward	+39.7K sh	—	—	39,700
2023-04-10	BVSBioventus Inc. · Restricted Stock UnitsA Award	SVP & General Counsel	AAward	+39.7K sh	—	—	39,700
2023-04-10	BVSBioventus Inc. · Stock Option (Right to Buy)A Award	SVP & General Counsel	AAward	+104K sh	—	—	103,600
2023-03-15	BVSBioventus Inc.S Sale	SVP & General Counsel	SSale	−3,409 sh	$1.39	−$4,737.487	45,610
2023-03-14	BVSBioventus Inc.M Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	+8,887 sh	—	—	49,019
2023-03-14	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	−8,887 sh	—	—	26,658
2022-04-04	BVSBioventus Inc.S Sale	SVP & General Counsel	SSale	−16K sh	$11.19	−$179K	40,132

Recent filings

Accepted (ET)
Apr 144
D'Adamio Anthony0001835184-26-000007
SEC(opens sec.gov)
Mar 174
D'Adamio Anthony0001835184-26-000005
SEC(opens sec.gov)
Feb 184
D'Adamio Anthony0001835184-26-000003
SEC(opens sec.gov)
Apr 154
D'Adamio Anthony0001578563-25-000218
SEC(opens sec.gov)
Apr 114
D'Adamio Anthony0001578563-25-000210
SEC(opens sec.gov)
Mar 184
D'Adamio Anthony0001578563-25-000184
SEC(opens sec.gov)

Companies

Bioventus Inc.SVP & General CounselBVS

Address

4721 EMPEROR BOULEVARD, SUITE 100

DURHAM, NC, 27703